Arno Therapeutics, Inc Patent Applications Rejected
2 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2017-11-29: Application 15825697; Invention METHODS FOR ONAPRISTONE SYNTHESIS DEHYDRATION AND DEPROTECTION; Applicant ARNO THERAPEUTICS, INC.; Status Abandoned -- Failure to Respond to an Office Action.
- 15523426: Invention ENHANCING THE ANTI-TUMOR, ANTI-VIRAL, AND ANTI-PROTOZOAN EFFECTS OF 2-AMINO-N-[4-[5-PHENANTHREN-2-YL-3-(TRIFLUOROMETHYL)PYRAZOL-1-YL] PHENYL]ACETAMIDE (OSU-03012) AND OTHER PHARMACEUTICAL DRUGS; Applicant ARNO THERAPEUTICS, INC.; Status Abandoned -- Incomplete Application (Pre-examination).
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2017-11-29 | 15825697 | METHODS FOR ONAPRISTONE SYNTHESIS DEHYDRATION AND DEPROTECTION | ARNO THERAPEUTICS, INC. | Abandoned -- Failure to Respond to an Office Action | US20180148471A1 | Ulf Tilstam Stefan Proniuk Ferry Brands | Belgium United States Netherlands | ZUCKER, PAUL A |
| 15523426 | ENHANCING THE ANTI-TUMOR, ANTI-VIRAL, AND ANTI-PROTOZOAN EFFECTS OF 2-AMINO-N-[4-[5-PHENANTHREN-2-YL-3-(TRIFLUOROMETHYL)PYRAZOL-1-YL] PHENYL]ACETAMIDE (OSU-03012) AND OTHER PHARMACEUTICAL DRUGS | ARNO THERAPEUTICS, INC. VIRGINIA COMMONWEALTH UNIVERSITY | Abandoned -- Incomplete Application (Pre-examination) | Paul DENT Alexander ZUKIWSKI Stefan PRONIUK | United States United States United States |